Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of lenvatinib (E7080) in Eisai parent studies
CTR20200388Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in Nonhematologic neoplasms, sponsored by Eisai Co., Ltd.. Started Dec 2020; status: completed.
02
Drugs
lenvatinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20200388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200388.